The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Professional Services Scientific, Architectural And Engineering Technical Activities Scientific Research And Development 72.11 - Research And Experimental Development On Biotechnology
95 jobs Number of planned job losses
Announcement Date
25 February 2025
Employment effect (start)
25 February 2025
Foreseen end date
30 June 2025
Description
Ryvu Therapeutics, a technology company headquartered in Kraków, will lay off about 30% of its employees (95 people).
The reason for the internal restructuring is financial and also the need to ensure an adequate cash runway - the company has decided to change its portfolio of ongoing projects. Employees will be laid off from 25 February to 30 June, 2025; after the layoffs, the company will continue to employ about 200 employees.
Ryvu Therapeutics is a Polish biotechnology company based in Kraków, Poland, active in drug discovery and regulatory research. The company was founded in 2007 as Selvita.
Digitisation and automation technologies, including artificial intelligence (AI), can affect working conditions in a variety of ways and their use in the workplace raises a host of new ethical concerns.
The retail banking sector is fertile ground for studying the impacts of digitalisation on work and employment. Financial services are increasingly provided online, without the intermediary of customer-facing institutions.
European labour markets have recovered strongly from COVID-19. By the end of 2021, little more than 18 months after the start of the pandemic, employment rates in the EU were almost at pre-crisis levels.
